Staff Publications: March 2019

  1. Amin A, Plimack ER, Ernstoff MS, Lewis LD, Bauer TM, McDermott DF, Carducci M, Kollmannsberger C, Rini BI, Heng DYC, Knox J, Voss MH, Spratlin J, Berghorn E, Yang L, Hammers HJ. Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for immunotherapy of cancer, 7(1):73, 2019. PMC6416882
  2. Barone FC, Marcinkiewicz C, Li J, Feng Y, Sternberg M, Lelkes PI, Rosenbaum-Halevi D, Gerstenhaber JA, Feuerstein GZ. Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV). International journal of nanomedicine, 14:1163-75, 2019. PMC6391148
  3. Blackwell KL, Zaman K, Qin S, Tkaczuk KHR, Campone M, Hunt D, Bryce R, Goldstein LJ, Study G. Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study. Clinical breast cancer, 19(2):97-104.e4, 2019.
  4. Blanke CD, Crowley J, Baker LH, Fisher RI. In Memoriam: Charles A. Coltman, 1930 to 2018. Journal of clinical oncology : official journal of the American Society of Clinical Oncology:Jco1900270, 2019.
  5. Chen OY, Cao H, Reinen JM, Qian T, Gou J, Phan H, De Vos M, Cannon TD. Resting-state brain information flow predicts cognitive flexibility in humans. Scientific reports, 9(1):3879, 2019. PMC6406001
  6. Cohn JA. Editorial Comment. The Journal of urology:10109701JU0000554404741846e, 2019.
  7. Cohn JA, Smith AL. Management of Occult Urinary Incontinence with Prolapse Surgery. Current urology reports, 20(5):23, 2019.
  8. DuBay DA, Ivankova NV, Herbey I, Redden DT, Holt C, Siminoff L, Fouad MN, Morinelli TA, Martin MY. An African American Perspective on Familial Notification of Becoming a Registered Organ Donor. Progress in transplantation (Aliso Viejo, Calif):1526924819835837, 2019.
  9. El-Deiry WS, Winer A, Slifker M, Taylor S, Adamson BJS, Meropol NJ, Ross EA. Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC). Frontiers in oncology, 9:142, 2019. PMC6426764
  10. Eze N, Lee JW, Yang DH, Zhu F, Neumeister V, Sandoval-Schaefer T, Mehra R, Ridge JA, Forastiere A, Chung CH, Burtness B. PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma. Oral oncology, 91:69-78, 2019.
  11. Fakhry C, Zhang Q, Gillison ML, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, 3rd, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. Cancer, 2019.
  12. Fang CY, Lee M, Feng Z, Tan Y, Levine F, Nguyen C, Ma GX. Community-Based Cervical Cancer Education: Changes in Knowledge and Beliefs Among Vietnamese American Women. Journal of community health, 2019.
  13. Ghosh J, Schultz B, Coutifaris C, Sapienza C. Highly variant DNA methylation in normal tissues identifies a distinct subclass of cancer patients. Advances in cancer research, 142:1-22, 2019.
  14. Gibney GT, Hamid O, Lutzky J, Olszanski AJ, Mitchell TC, Gajewski TF, Chmielowski B, Hanks BA, Zhao Y, Newton RC, Maleski J, Leopold L, Weber JS. Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma. Journal for immunotherapy of cancer, 7(1):80, 2019.
  15. Guindalini RS, Zheng YL, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao HY, Romero IL, Hong S, Livingston R, Jaskowiak N, Wang XM, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, Olopade OI. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clinical Cancer Research, 25(6):1786-94, 2019.
  16. Hall KW, Percec S, Klein ML. Polymer nucleation under high-driving force, long-chain conditions: Heat release and the separation of time scales. The Journal of chemical physics, 150(11):114901, 2019.
  17. Hayakawa K, Li YS, Shinton SA, Bandi SR, Formica AM, Brill-Dashoff J, Hardy RR. Crucial Role of Increased Arid3a at the Pre-B and Immature B Cell Stages for B1a Cell Generation. Frontiers in Immunology, 10, 2019.
  18. He AR, Cohen RB, Denlinger CS, Sama A, Birnbaum A, Hwang J, Sato T, Lewis N, Mynderse M, Niland M, Giles J, Wallin J, Moser B, Zhang W, Walgren R, Plimack ER. First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. The oncologist, 2019.
  19. Kantidze OL, Luzhin AV, Nizovtseva EV, Safina A, Valieva ME, Golov AK, Velichko AK, Lyubitelev AV, Feofanov AV, Gurova KV, Studitsky VM, Razin SV. The anti-cancer drugs curaxins target spatial genome organization. Nature communications, 10(1):1441, 2019.
  20. Karpova Y, Wu C, Divan A, McDonnell ME, Hewlett E, Makhov P, Gordon J, Ye M, Reitz AB, Childers WE, Skorski T, Kolenko V, Tulin AV. Non-NAD-like PARP-1 inhibitors in prostate cancer treatment. Biochemical pharmacology, 2019.
  21. Kasagi Y, Dods K, Wang JX, Chandramouleeswaran PM, Benitez AJ, Gambanga F, Kluger J, Ashorobi T, Gross J, Tobias JW, Klein-Szanto AJ, Spergel JM, Cianferoni A, Falk GW, Whelan KA, Nakagawa H, Muir AB. Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α. Journal of Allergy and Clinical Immunology, 2019.
  22. Kaushik A, Yndart A, Atluri V, Tiwari S, Tomitaka A, Gupta P, Jayant RD, Alvarez-Carbonell D, Khalili K, Nair M. Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection. Scientific reports, 9(1):3928, 2019. PMC6408460
  23. Kentish-Barnes N, Siminoff LA, Walker W, Urbanski M, Charpentier J, Thuong M, Sarti A, Shemie SD, Azoulay E. A narrative review of family members’ experience of organ donation request after brain death in the critical care setting. Intensive care medicine, 45(3):331-42, 2019.
  24. Kiseleva AA, Korobeynikov VA, Nikonova AS, Zhang P, Makhov P, Deneka AY, Einarson MB, Serebriiskii IG, Liu H, Peterson JR, Golemis EA. Unexpected activities in regulating ciliation contribute to off-target effects of targeted drugs. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019.
  25. Liao L, Alicea-Velázquez NL, Langbein L, Niu X, Cai W, Cho EA, Zhang M, Greer CB, Yan Q, Cosgrove MS, Yang H. High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1. Molecular Oncology, 2019.
  26. Liu Y, Barta SK. Diffuse Large B cell Lymphoma: 2019 update on diagnosis, risk-stratification and treatment. American journal of hematology, 2019.
  27. Manne SL, Kashy DA, Zaider T, Kissane D, Lee D, Kim IY, Heckman CJ, Penedo FJ, Murphy E, Virtue SM. Couple-focused interventions for men with localized prostate cancer and their spouses: A randomized clinical trial. British journal of health psychology, 2019.
  28. Martin DDO, Kanuparthi PS, Holland SM, Sanders SS, Jeong HK, Einarson MB, Jacobson MA, Thomas GM. Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content Screening. Scientific reports, 9(1):3632, 2019. PMC6403299
  29. Martin JM, Wu H, Barta SK. CD30+ T-cell lymphoproliferative disorders. Chinese clinical oncology, 8(1):4, 2019.
  30. Martinez Chanza N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study. The Lancet Oncology, 2019.
  31. Masic S, Smaldone MC. Treatment delays for muscle-invasive bladder cancer. Cancer, 2019. Editorial
  32. Mateo AM, Mazor AM, DeMora L, Sigurdson ER, Handorf EA, Daly JM, Aggon AA, Obeid E, Hayes SB, Bleicher RJ. Patterns of Care and Efficacy of Chemotherapy and Radiotherapy in Skin-Involved Breast Cancers of All Sizes. Clinical breast cancer, 2019.
  33. Matulonis UA, Birrer MJ, O’Malley DM, Moore KN, Konner J, Gilbert L, Martin LP, Bauer TM, Oza AM, Malek K, Pinkas J, Kim SK. Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Clinical Cancer Research, 25(6):1727-36, 2019.
  34. Michael JV, Goldfinger LE. Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting. Seminars in Cancer Biology, 54:121-30, 2019.
  35. Milliron BJ, Bruneau M, Obeid E, Gross L, Bealin L, Smaltz C, Giri VN. Diet assessment among men undergoing genetic counseling and genetic testing for inherited prostate cancer: Exploring a teachable moment to support diet intervention. The Prostate, 2019.
  36. Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Annals of surgical oncology, 2019.
  37. Modi V, Dunbrack RL, Jr. Defining a new nomenclature for the structures of active and inactive kinases. Proceedings of the National Academy of Sciences of the United States of America, 2019.
  38. Moore KN, Bendell JC, LoRusso PM, Olszanski AJ, Zwick-Wallasch E, Jansen M, Vandell AG, Senaldi G. First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors. Investigational New Drugs, 37(1):147-58, 2019.
  39. Mortazavi SMJ. Re: Microbiological colonization of healthcare workers’ mobile phones in a tertiary-level Italian intensive care unit. Intensive & critical care nursing, 2019. Letter
  40. Mortazavi SMJ. Acquired Antibiotic Resistance in Escherichia coli Exposed to Simulated Microgravity: Possible Role of Other Space Stressors and Adaptive Responses. mBio, 10(2), 2019. Letter
  41. Mortazavi SMJ, Bevelacqua JJ. Comment on “Using Flight-Time to Contextualize Radiological Dose”. Physics Teacher, 57(2):67, 2019.
  42. Mortazavi SMJ, Malakoutikhah M, Zare A, Tajvar A, Derakhshan Jazari M. Commentary regarding “Factors associated with mental health among high school students in Iran: Does mobile phone overuse associate with poor mental health?”. Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc, 2019. Comment
  43. Naito S, Ichiyanagi O, Ito H, Kabasawa T, Kanno H, Narisawa T, Fukuhara H, Yagi M, Kurota Y, Yamagishi A, Sakurai T, Nishida H, Kawazoe H, Yamanobe T, Kato T, Makhov P, Kolenko VM, Yamakawa M, Tsuchiya N. Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma. Oncology letters, 17(4):3910-8, 2019. PMC6403496
  44. Pang M, Koop A, Brahmbhatt B, Bartel MJ, Woodward TA. Comparison of flexible endoscopic cricopharyngeal myectomy and myotomy approaches for Zenker diverticulum repair. Gastrointestinal Endoscopy, 89(4):880-6, 2019.
  45. Patel D, Handorf E, von Mehren M, Martin L, Movva S. Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage. Sarcoma, 2019:3561501, 2019. PMC6387708
  46. Pope JL, Yang Y, Newsome RC, Sun W, Sun X, Ukhanova M, Neu J, Issa JP, Mai V, Jobin C. Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant Isolate. Scientific reports, 9(1):3380, 2019. PMC6399262
  47. Reese JB, Sorice K, Lepore SJ, Daly MB, Tulsky JA, Beach MC. Patient-clinician communication about sexual health in breast cancer: A mixed-methods analysis of clinic dialogue. Patient Education and Counseling, 102(3):436-42, 2019.
  48. Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC, 3rd, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS, Jr. US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials. Journal of oncology practice:Jop1800638, 2019.
  49. Rodriguez-Emmenegger C, Xiao Q, Kostina NY, Sherman SE, Rahimi K, Partridge BE, Li S, Sahoo D, Reveron Perez AM, Buzzacchera I, Han H, Kerzner M, Malhotra I, Moller M, Wilson CJ, Good MC, Goulian M, Baumgart T, Klein ML, Percec V. Encoding biological recognition in a bicomponent cell-membrane mimic. Proceedings of the National Academy of Sciences of the United States of America, 116(12):5376-82, 2019. PMC6431222
  50. Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM. Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology:Jco1802158, 2019.
  51. Santucci-Pereira J, Zeleniuch-Jacquotte A, Afanasyeva Y, Zhong H, Slifker M, Peri S, Ross EA, Lopez de Cicco R, Zhai Y, Nguyen T, Sheriff F, Russo IH, Su Y, Arslan AA, Bordas P, Lenner P, Ahman J, Landstrom Eriksson AS, Johansson R, Hallmans G, Toniolo P, Russo J. Genomic signature of parity in the breast of premenopausal women. Breast cancer research : BCR, 21(1):46, 2019.
  52. Shapovalov M, Vucetic S, Dunbrack RL, Jr. A new clustering and nomenclature for beta turns derived from high-resolution protein structures. PLoS computational biology, 15(3):e1006844, 2019.
  53. Shih JC, Olszanski AJ. Orally Administered Cancer Therapy: Breaking Down Barriers to Adherence and Quality of Life. Journal of the National Comprehensive Cancer Network, 17(3):290-2, 2019.
  54. Srivastava A, Joshi SS. Editorial Comment. The Journal of urology:10109701JU0000554385561060f, 2019. Editorial
  55. Tang JA, Lango MN. Diverging incidence trends for larynx and tonsil cancer in low socioeconomic regions of the US. Oral oncology, 91:65-8, 2019.
  56. Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O’Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G. Pancreatic Adenocarcinoma, Version 1.2019. Journal of the National Comprehensive Cancer Network, 17(3):203-10, 2019.
  57. Terry MB, Daly MB, Phillips KA, Ma X, Zeinomar N, Leoce N, Dite GS, MacInnis RJ, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, Weideman PC, Glendon G, Buchsbaum R, Andrulis IL, John EM, Buys SS, Hopper JL. Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk. Journal of the National Cancer Institute, 111(3):331-4, 2019.
  58. Thompson JA, Schneider BJ, Brahmer J, Andrews S, Armand P, Bhatia S, Budde LE, Costa L, Davies M, Dunnington D, Ernstoff MS, Frigault M, Hoffner B, Hoimes CJ, Lacouture M, Locke F, Lunning M, Mohindra NA, Naidoo J, Olszanski AJ, Oluwole O, Patel SP, Reddy S, Ryder M, Santomasso B, Shofer S, Sosman JA, Wahidi M, Wang YH, Johnson-Chilla A, Scavone JL. Management of Immunotherapy-Related Toxicities. Version 1.2019. Journal of the National Comprehensive Cancer Network, 17(3):255-88, 2019.
  59. Turchetti D, Zuntini R, Tricarico R. BRCA2 in Ovarian Development and Function. The New England journal of medicine, 380(11):1086-7, 2019. Reply
  60. Upshaw JN, O’Neill A, Carver JR, Dimond EP, Denlinger CS, Kircher SM, Wagner LI, Ky B, Brell JM. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal. Clinical Colorectal Cancer, 18(1):44-51, 2019.
  61. Wissler HL, Ehlerding EB, Lyu Z, Zhao Y, Zhang S, Eshraghi A, Buuh ZY, McGuth JC, Guan Y, Engle JW, Bartlett SJ, Voelz VA, Cai W, Wang RE. Site-Specific Immuno-PET Tracer to Image PD-L1. Molecular pharmaceutics, 2019.
  62. Yadavalli SS, Xiao Q, Sherman SE, Hasley WD, Klein ML, Goulian M, Percec V. Bioactive cell-like hybrids from dendrimersomes with a human cell membrane and its components. Proceedings of the National Academy of Sciences of the United States of America, 116(3):744-52, 2019. PMC6338876
  63. Zou KH, Evers K. Image Perception and Diagnostic Accuracy of Digital Mammography: An Editorial. Academic radiology, 2019. Editorial
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s